Survivin was elevated in serum sEVs from early-stage BC and TNBC patients, and its splice variants were inversely correlated to tumour grade in BC [159], suggesting the expression of survivin and its variants might be a potential indicator of BC progression. The gene discussed is BIRC5; the disease is breast cancer.